111In-DOTA-urotensin-II

N/A

Report date: 2025/01/26 15:36:16

Base Information

Drug Name111In-DOTA-urotensin-II
Drug Alias Nameradiolabeled DOTA-peptide ligands targeting urotensin receptor of urotensin-II (Inserm and Sherbrooke)
ClassificationRadiation-emitting products
Mechanisms of ActionUrotensin II modulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleUniversity Of Sherbrooke
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A